Home |
Free Dividend Report |
Stock Splits Calendar |
CSTL Stock Split History |
Preferred Stock Newsletter |
CSTL Options Chain |
Stock Message Boards |
Castle Biosciences (CSTL) has 0 splits in our Castle Biosciences stock split history database.
Looking at the Castle Biosciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Castle Biosciences shares, starting with a $10,000 purchase of CSTL, presented on a split-history-adjusted basis factoring in the complete Castle Biosciences stock split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/26/2019 | |
End date: | 04/26/2024 | |
Start price/share: | $22.99 | |
End price/share: | $20.34 | |
Dividends collected/share: | $0.00 | |
Total return: | -11.53% | |
Average Annual Total Return: | -2.54% | |
Starting investment: | $10,000.00 | |
Ending investment: | $8,848.23 | |
Years: | 4.76 |
About Castle Biosciences |
Castle Biosciences is a commercial-stage dermatological diagnostics company focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes. Co.'s main product, DecisionDx-Melanoma, is a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis or recurrence for patients diagnosed with invasive cutaneous melanoma, a deadly skin cancer. Co. has commercially launched its cutaneous squamous cell carcinoma (SCC) proprietary GEP test, DecisionDx®-SCC, for use in patients with one or more risk factors. According to our Castle Biosciences stock split history records, Castle Biosciences has had 0 splits. |
CSTL Split History Table | |
Date | Ratio |
Castle Biosciences Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.